Yossi Maimon
2020 - Ayala Pharmaceuticals
In 2020, Yossi Maimon earned a total compensation of $862.5K as Chief Financial Officer at Ayala Pharmaceuticals, a 19% increase compared to previous year.
Compensation breakdown
| Bonus | $144,144 |
|---|---|
| Non-Equity Incentive Plan | $116,364 |
| Salary | $288,288 |
| Stock Awards | $170,280 |
| Other | $143,386 |
| Total | $862,462 |
Maimon received $288.3K in salary, accounting for 33% of the total pay in 2020.
Maimon also received $144.1K in bonus, $116.4K in non-equity incentive plan, $170.3K in stock awards and $143.4K in other compensation.
Rankings
In 2020, Yossi Maimon's compensation ranked 9,205th out of 13,090 executives tracked by ExecPay. In other words, Maimon earned more than 29.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,205 out of 13,090 | 30th |
Division Manufacturing | 3,933 out of 5,617 | 30th |
Major group Chemicals And Allied Products | 1,595 out of 2,248 | 29th |
Industry group Drugs | 1,394 out of 1,948 | 28th |
Industry Biological Products, Except Diagnostic Substances | 325 out of 411 | 21st |
Source: SEC filing on April 27, 2021.
Maimon's colleagues
We found two more compensation records of executives who worked with Yossi Maimon at Ayala Pharmaceuticals in 2020.